DE69120287D1 - Aminosulfonylharnstoff-acat-inhibitoren - Google Patents

Aminosulfonylharnstoff-acat-inhibitoren

Info

Publication number
DE69120287D1
DE69120287D1 DE69120287T DE69120287T DE69120287D1 DE 69120287 D1 DE69120287 D1 DE 69120287D1 DE 69120287 T DE69120287 T DE 69120287T DE 69120287 T DE69120287 T DE 69120287T DE 69120287 D1 DE69120287 D1 DE 69120287D1
Authority
DE
Germany
Prior art keywords
compounds
acat
aminosulfonylharnstoff
inhibitoren
acat inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69120287T
Other languages
English (en)
Other versions
DE69120287T2 (de
Inventor
Joseph PICARD
Drago SLISKOVIC
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE69120287D1 publication Critical patent/DE69120287D1/de
Publication of DE69120287T2 publication Critical patent/DE69120287T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69120287T 1990-11-07 1991-11-05 Aminosulfonylharnstoff-acat-inhibitoren Expired - Fee Related DE69120287T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61028790A 1990-11-07 1990-11-07
US07/747,040 US5214206A (en) 1990-11-07 1991-08-19 Aminosulfonyl urea acat inhibitors
PCT/US1991/008223 WO1992008694A1 (en) 1990-11-07 1991-11-05 Aminosulfonyl urea acat inhibitors

Publications (2)

Publication Number Publication Date
DE69120287D1 true DE69120287D1 (en) 1996-07-18
DE69120287T2 DE69120287T2 (de) 1996-10-10

Family

ID=27086230

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120287T Expired - Fee Related DE69120287T2 (de) 1990-11-07 1991-11-05 Aminosulfonylharnstoff-acat-inhibitoren

Country Status (16)

Country Link
US (2) US5214206A (de)
EP (1) EP0556322B1 (de)
JP (2) JP3256541B2 (de)
AT (1) ATE139226T1 (de)
AU (1) AU657928B2 (de)
CA (1) CA2094806C (de)
DE (1) DE69120287T2 (de)
DK (1) DK0556322T3 (de)
ES (1) ES2088128T3 (de)
GR (1) GR3020355T3 (de)
IE (1) IE75379B1 (de)
MX (1) MX9101958A (de)
NZ (1) NZ240481A (de)
PH (1) PH30665A (de)
PT (1) PT99435B (de)
WO (1) WO1992008694A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3095413B2 (ja) * 1990-12-28 2000-10-03 帝人株式会社 ベンゾオキサ縮合環化合物
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
US5491170A (en) * 1994-12-19 1996-02-13 Warner-Lambert Company β-carboxy sulfonamide ACAT inhibitors
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
EP1281399A3 (de) * 2001-08-01 2004-02-11 Warner-Lambert Company Hemmer mit doppelter Wirkung auf Wachsester- und Cholesterylestersynthese zur Hemmung der Sebumproduktion
ES2675914T3 (es) * 2010-11-16 2018-07-13 Texas Heart Institute Agonistas que mejoran la unión de células que expresan integrina a receptores de integrina
CN103288749A (zh) * 2013-03-04 2013-09-11 盐城工学院 可作除草剂的氨基磺酰脲类化合物
WO2016053107A1 (en) * 2014-10-03 2016-04-07 Synaffix B.V. Sulfamide linker, conjugates thereof, and methods of preparation
CA2975192A1 (en) * 2015-02-16 2016-08-25 The University Of Queensland Sulfonylureas and related compounds and use of same
CA3014487A1 (en) * 2016-02-16 2017-08-24 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Sulfonylureas and related compounds and use of same
MA56075A (fr) 2017-07-07 2022-04-06 Inflazome Ltd Nouveaux composés de sulfonamide carboxamide
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
BR112021002770A2 (pt) * 2018-08-15 2021-05-04 Inflazome Limited compostos inovadores de sulfonamidaurea

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2312404A (en) * 1939-11-22 1943-03-02 Haack Erich Method of preparing n-sulphonylureas
CH396872A (de) * 1959-08-13 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Harnstoffe
US3242174A (en) * 1962-02-06 1966-03-22 Pfizer & Co C 1-(tertiary aminosulfonyl)-3-(hydrocarbon) ureas
GB990860A (en) * 1962-02-08 1965-05-05 Pfizer & Co C N,n-disubstituted sulfamylureas and compositions thereof
US3245982A (en) * 1962-03-27 1966-04-12 Pfizer & Co C Sulfamylsemicarbazides
DE1518541A1 (de) * 1965-03-16 1969-09-11 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Sulfonylharnstoffen und Sulfonylsemicarbaziden
CH649081A5 (de) * 1982-01-12 1985-04-30 Ciba Geigy Ag Triaza-verbindungen.

Also Published As

Publication number Publication date
CA2094806C (en) 2004-11-02
ATE139226T1 (de) 1996-06-15
DE69120287T2 (de) 1996-10-10
ES2088128T3 (es) 1996-08-01
PT99435A (pt) 1992-12-31
JP2001026574A (ja) 2001-01-30
WO1992008694A1 (en) 1992-05-29
CA2094806A1 (en) 1992-05-08
US5214206A (en) 1993-05-25
JPH06501707A (ja) 1994-02-24
AU657928B2 (en) 1995-03-30
MX9101958A (es) 1992-07-08
EP0556322B1 (de) 1996-06-12
JP3256541B2 (ja) 2002-02-12
NZ240481A (en) 1994-06-27
IE913874A1 (en) 1992-05-20
AU8959791A (en) 1992-06-11
EP0556322A1 (de) 1993-08-25
IE75379B1 (en) 1997-09-10
PH30665A (en) 1997-09-16
DK0556322T3 (da) 1996-10-14
PT99435B (pt) 1999-04-30
US5288757A (en) 1994-02-22
GR3020355T3 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
DE69726577D1 (en) Kristallin form i von clarithromycin
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
SE9704546D0 (sv) Novel compounds
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
DE69905170D1 (en) Thiazolopyrimidinderivate
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
MX9702170A (es) Uso de inhibidores de la aromatasa para la produccion de un agente farmaceutico para el tratamiento de una deficiencia de androgeno relativa en los hombres.
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
SE9802937D0 (sv) Novel compounds
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
IL106237A0 (en) Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee